Post-Marketing Perspectives
To keep up with the late phase evolution, you need the full picture of the drug development lifecycle, including the critical transition to the commercial market. Our experience in every area of clinical and commercialization services gives us deep insight into how you can tackle today’s late phase challenges — and win.
Sound Responses to the Changing Late-Phase Game
Dipti Amin, Senior Vice President and Global Head
Late Phase and Safety Services
Next Generation Pharmaceutical Europe, Q3 2009
Late Phase Studies: An Early Priority
Dipti Amin, Senior Vice President and Global Head
Late Phase and Safety Services
Next Generation Pharmaceutical US, Q4 2009
